Markedsdata leveret af TwelveData og Morningstar
22nd Century Group Inc. is a tobacco products and plant biotechnology company focused on reduced nicotine tobacco solutions and related plant science applications. The company develops and commercializes proprietary tobacco products designed to lower nicotine content, including very low nicotine cigarettes, branded filtered cigars, and other combustible tobacco offerings. It also provides contract manufacturing services for third-party tobacco brands, supporting conventional cigarettes and filtered cigars through turnkey production capabilities. In addition to its tobacco segment, 22nd Century Group works with hemp and cannabis-related plant technologies, applying genetic engineering, gene-editing, and modern breeding methods to modify plant characteristics. Headquartered in Mocksville, North Carolina, 22nd Century Group serves the consumer goods, life sciences, and agricultural biotechnology markets, where it plays a specialized role in tobacco harm reduction and plant-based product development.